Cytocybernetics Inc.

North Tonawanda, NY

UEI
G69NH6PMLT75
CAGE
756P3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
  • Woman Owned Business
  • Woman Owned Small Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
5000 Tonawanda Creek Rd, North Tonawanda, NY 14120, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $41,126

Contract awards

Award Agency Obligated Awarded
Cybercyte 1.0 complete system 36C24123P0881 Veterans Integrated Service Network 1 (VHA) $41,126
Cybercyte DC1 dynamic clamp system 36C24E22P0021 Veterans Integrated Service Network 4 (VHA) $20,000

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Cytocybernetics Inc. is a for-profit, woman-owned small business that provides goods and services to U.S. federal government agencies, primarily in the areas of biomedical research and healthcare services. The company specializes in developing cybernetic systems and predictive analytics platforms leveraging mathematical modeling and quantitative analysis.

Through prime federal contract awards, Cytocybernetics has provided complete cybernetic systems, dynamic clamp systems, and related hardware and software to the Department of Veterans Affairs. These systems support VA efforts to provide quality healthcare services to veterans. All prime contract awards listed were made directly to Cytocybernetics as the prime contractor responsible for fulfillment, without the use of major subcontractors.

Through federal grants, Cytocybernetics has developed integrated hardware and software platforms for real-time neuron simulation applications, funded by the National Institute of Neurological Disorders and Stroke. The company has also received awards from the National Science Foundation to develop a predictive analytics platform to improve identification of potential drug-induced cardiac side effects during the FDA approval process. Additional awards have supported developing systems to optically determine absolute membrane potential in human cells, funded by the National Heart, Lung and Blood Institute, as well as complementary research and development projects related to modeling drug interactions, funded by the NSF Division of Industrial Innovation.

Quick answers

Is Cytocybernetics Inc. registered in SAM.gov?

Yes. Cytocybernetics Inc.'s SAM.gov registration is active through October 2, 2027.

What is Cytocybernetics Inc.'s CAGE code?

Cytocybernetics Inc.'s CAGE code is 756P3, and its Unique Entity ID (UEI) is G69NH6PMLT75.

How much has Cytocybernetics Inc. received in federal contracts?

Federal contracts obligated $41,126 to Cytocybernetics Inc. in fiscal years 2023 through 2027.

What is Cytocybernetics Inc.'s most recent federal award?

Cytocybernetics Inc.'s most recent federal contract award is Cybercyte 1.0 complete system (36C24123P0881), from Veterans Integrated Service Network 1 (VHA), on July 11, 2023.

On GovTribe

See Cytocybernetics Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe